Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XYWAV in Idiopathic Hypersomnia or Narcolepsy
NCT05875974Phase 4Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jul 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate in idiopathic hypersomnia (IH), narcolepsy, sponsored by Jazz Pharmaceuticals plc. Started Jul 2023; status: completed.
02
Drugs
sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate
03
Conditions
idiopathic hypersomnia (IH)narcolepsy
Beyond the preview
Go deeper on NCT05875974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05875974.